Barclays Upgrades Canadian Solar (CSIQ) to Equalweight
More News related to CSIQ
- Solar Energy Initiatives, Inc. Signs Financing Agreement for Municipal Solar Projects
- Canadian Solar (CSIQ) Posts Q3 EPS of $0.69, Tops Views; Guides Q409, FY09, and FY10 Shipments
- Canadian Solar Reports Third Quarter 2009 Results and Issues 2010 Guidance
- Trading Radar for 11/17: Home Depot (HD), Saks (SKS), Target (TGT), Autodesk (ADSK), La-Z-Boy (LZB) Report
- SmallCapSentinel.com: Solar Solutions in Arizona
More News related to Upgrades
- RW Baird Makes Positive Comments on Incyte (INCY) Following Novartis Deal
- Incyte (INCY) Strikes Major Drug Development Deal with Noavartis
- Human Genome Sciences (HGSI) Submits BLA to U.S. FDA for Hep C Treatment ZALBIN
- Incyte (INCY) In License Agreement With Novartis, Worth Up to $1 Billion
Barclays Capital upgrades Canadian Solar (Nasdaq: CSIQ) from Underweight to Equalweight. The firm also raised its price target from $11.50 to $16.
With shares of Canadian Solar trading around $14.69 in the pre-market session, the firm's new price target represents potential upside of about 8.9%.
Click here to see all the upgrades/downgrades on shares of Canadian Solar.
Canadian Solar Inc., together with its subsidiaries, engages in the design, development, manufacture, and marketing of solar cell and solar module products that convert sunlight into electricity for various uses in Canada and internationally.
Related Categories
UpgradesStocks Mentioned
+0.01Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
